Average Co-Inventor Count = 4.83
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Scholar Rock, Inc. (8 from 30 patents)
2. Pfizer Corporation (5 from 4,455 patents)
3. Merck Sharp + Dohme B.v. (2 from 55 patents)
4. Merck Sharp + Dohme Corp. (1 from 2,405 patents)
5. Msd Oss B.v. (1 from 17 patents)
6. Merck Sharpe & Dohme B.v. (1 from 1 patent)
18 patents:
1. 12358992 - LTBP complex-specific inhibitors of TGF-beta 1 and uses thereof
2. 12281159 - TGFβ antibodies, methods and uses
3. 12252531 - Methods of screening for high-affinity, isoform-selective TGFβ1 inhibitors
4. 12168698 - Tissue factor pathway inhibitor antibodies and uses thereof
5. 12122823 - Isoform-selective TGFB1 inhibitors and use thereof
6. 11643459 - TGFβ1-binding immunoglobulins and use thereof
7. 11634504 - Tissue factor pathway inhibitor antibodies and uses thereof
8. 11439704 - Methods for using anti-myostatin antibodies
9. 11130803 - Isoform-selective TGFβ1 inhibitors and use thereof
10. 11117961 - Antibodies to human programmed death receptor PD-1
11. 10875929 - Tissue factor pathway inhibitor antibodies and uses thereof
12. 10751413 - Anti-pro/latent-Myostatin antibodies and uses thereof
13. 10550200 - Tissue factor pathway inhibitor antibodies and uses thereof
14. 9834605 - Antibodies to human programmed death receptor PD-1
15. 9428577 - Platelet-derived growth factor B specific antibodies and compositions and uses thereof